The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | AI-driven incidental pulmonary nodule program to increase lung cancer detection
Luis Raez, MD, FACP, FASCO, Memorial Cancer Institute, Pembroke Pines, FL, discusses an artificial intelligence (AI)-driven incidental pulmonary nodule program to increase lung cancer detection. The program checked routine scans for pulmonary nodules and patients with incidental findings were enrolled in the program for follow-up. Five times more lung cancers were found using the program than in the regular lung cancer screening program, including those who would not have qualified for screening. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
